MacroGenics

MacroGenics is a clinical-stage biopharmaceutical company headquartered in Rockville, Maryland, focused on discovering and developing next-generation antibody-based therapies to improve the lives of cancer patients. The company leverages its proprietary antibody technology platforms to advance a pipeline of innovative oncology medicines.